Biocept reports second quarter 2022 financial results

San diego--( business wire )--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and six months ended june 30, 2022 and provides a business update.
BIOC Ratings Summary
BIOC Quant Ranking